思创医惠：股票交易异常波动

Core Viewpoint - The stock of Sichuang Medical has experienced significant price fluctuations, with a cumulative increase of over 30% in two consecutive trading days, prompting an inquiry into the reasons behind this abnormal trading activity [1] Group 1: Stock Performance and Trading Activity - Sichuang Medical's stock price increased by over 30% over two trading days, leading to an investigation by the Shenzhen Stock Exchange regarding abnormal trading [1] - The company confirmed that there are no undisclosed significant events that could impact the stock price, and its operational status remains normal [1] Group 2: Share Transfer and Control Change - On November 15, 2025, the largest shareholder, Lu Nan, signed a share transfer agreement with Wei Naixu, the company's director and general manager, which will result in a change of control [1] - Following the completion of the share transfer and voting rights delegation, Wei Naixu will indirectly hold 7.47% of the company's shares and possess 13.18% of the voting rights, making Cangnan Xincheng the controlling shareholder [1] - The change in control from no actual controller to Wei Naixu is subject to approval by the company's shareholders' meeting and compliance confirmation from the Shenzhen Stock Exchange, indicating uncertainty in the final implementation [1]